Close Menu

NEW YORK (GenomeWeb) – Precision for Medicine said today that it has acquired Houston-based ApoCell, which specializes in the identification and analysis of biomarkers in both tissue and liquid biopsy.

Specific terms of the deal were not disclosed.

The acquisition adds ApoCell's ApoStream liquid biopsy technology and its expertise in tissue genomic profiling to Precision's existing suite of specialty laboratory and biomarker informatics services, which include cell-based assays and various immune monitoring technologies.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

The Hill reports President Donald Trump issued an executive directing federal agencies to cut the number of board and advisory committees they have.

The New York Times reports that researchers are combining tools to more quickly develop crops to feed a growing population and cope with shifting climates.

Scientists in Canada are looking to the UK's plan to sequence children with rare conditions for inspiration, the National Post reports.

In PNAS this week: copy number changes arose during polar bear evolution, genomic and transcriptomic analysis of the Siberian hamster, and more.